nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—CYP3A5—Beclomethasone—psoriasis	0.064	0.113	CbGbCtD
Risperidone—CYP2D6—Hydroxyurea—psoriasis	0.0297	0.0527	CbGbCtD
Risperidone—CYP3A7—Hydrocortisone—psoriasis	0.0272	0.0483	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0272	0.0483	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0257	0.0456	CbGbCtD
Risperidone—CYP3A7—Cyclosporine—psoriasis	0.0257	0.0456	CbGbCtD
Risperidone—CYP3A5—Mycophenolate mofetil—psoriasis	0.0255	0.0451	CbGbCtD
Risperidone—CYP3A4—Calcitriol—psoriasis	0.0222	0.0394	CbGbCtD
Risperidone—CYP3A5—Hydrocortisone—psoriasis	0.0204	0.0362	CbGbCtD
Risperidone—CYP3A5—Cyclosporine—psoriasis	0.0193	0.0342	CbGbCtD
Risperidone—CYP2D6—Cholecalciferol—psoriasis	0.018	0.0319	CbGbCtD
Risperidone—CYP3A4—Methoxsalen—psoriasis	0.0173	0.0306	CbGbCtD
Risperidone—CYP3A7—Dexamethasone—psoriasis	0.0169	0.03	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.0169	0.03	CbGbCtD
Risperidone—ABCB1—Mycophenolate mofetil—psoriasis	0.0166	0.0294	CbGbCtD
Risperidone—ABCB1—Betamethasone—psoriasis	0.0142	0.0252	CbGbCtD
Risperidone—ABCB1—Prednisolone—psoriasis	0.014	0.0249	CbGbCtD
Risperidone—ABCB1—Hydrocortisone—psoriasis	0.0133	0.0236	CbGbCtD
Risperidone—ABCB1—Prednisone—psoriasis	0.0132	0.0235	CbGbCtD
Risperidone—CYP3A5—Dexamethasone—psoriasis	0.0127	0.0225	CbGbCtD
Risperidone—ABCB1—Cyclosporine—psoriasis	0.0126	0.0223	CbGbCtD
Risperidone—CYP2D6—Cyclosporine—psoriasis	0.0118	0.021	CbGbCtD
Risperidone—CYP3A4—Cholecalciferol—psoriasis	0.0115	0.0203	CbGbCtD
Risperidone—CYP3A4—Mycophenolate mofetil—psoriasis	0.00993	0.0176	CbGbCtD
Risperidone—CYP3A4—Triamcinolone—psoriasis	0.00993	0.0176	CbGbCtD
Risperidone—CYP3A4—Betamethasone—psoriasis	0.00852	0.0151	CbGbCtD
Risperidone—CYP3A4—Prednisolone—psoriasis	0.00841	0.0149	CbGbCtD
Risperidone—ABCB1—Dexamethasone—psoriasis	0.00827	0.0147	CbGbCtD
Risperidone—CYP3A4—Hydrocortisone—psoriasis	0.00797	0.0141	CbGbCtD
Risperidone—CYP3A4—Prednisone—psoriasis	0.00794	0.0141	CbGbCtD
Risperidone—CYP2D6—Dexamethasone—psoriasis	0.00779	0.0138	CbGbCtD
Risperidone—CYP3A4—Cyclosporine—psoriasis	0.00752	0.0133	CbGbCtD
Risperidone—ABCB1—Methotrexate—psoriasis	0.00665	0.0118	CbGbCtD
Risperidone—CYP3A4—Dexamethasone—psoriasis	0.00496	0.00878	CbGbCtD
Risperidone—Pain—Prednisolone—psoriasis	5.61e-05	0.000143	CcSEcCtD
Risperidone—Haemorrhage—Methotrexate—psoriasis	5.61e-05	0.000143	CcSEcCtD
Risperidone—Hepatitis—Methotrexate—psoriasis	5.61e-05	0.000143	CcSEcCtD
Risperidone—Urticaria—Mycophenolate mofetil—psoriasis	5.59e-05	0.000143	CcSEcCtD
Risperidone—Headache—Mycophenolic acid—psoriasis	5.59e-05	0.000142	CcSEcCtD
Risperidone—Decreased appetite—Hydrocortisone—psoriasis	5.57e-05	0.000142	CcSEcCtD
Risperidone—Pharyngitis—Methotrexate—psoriasis	5.57e-05	0.000142	CcSEcCtD
Risperidone—Abdominal pain—Mycophenolate mofetil—psoriasis	5.56e-05	0.000142	CcSEcCtD
Risperidone—Body temperature increased—Mycophenolate mofetil—psoriasis	5.56e-05	0.000142	CcSEcCtD
Risperidone—Urinary tract disorder—Methotrexate—psoriasis	5.54e-05	0.000141	CcSEcCtD
Risperidone—Gastrointestinal disorder—Hydrocortisone—psoriasis	5.54e-05	0.000141	CcSEcCtD
Risperidone—Fatigue—Hydrocortisone—psoriasis	5.53e-05	0.000141	CcSEcCtD
Risperidone—Vision blurred—Prednisone—psoriasis	5.51e-05	0.00014	CcSEcCtD
Risperidone—Urethral disorder—Methotrexate—psoriasis	5.5e-05	0.00014	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Triamcinolone—psoriasis	5.5e-05	0.00014	CcSEcCtD
Risperidone—Pain—Hydrocortisone—psoriasis	5.48e-05	0.00014	CcSEcCtD
Risperidone—Anaphylactic shock—Dexamethasone—psoriasis	5.48e-05	0.00014	CcSEcCtD
Risperidone—Oedema—Dexamethasone—psoriasis	5.48e-05	0.00014	CcSEcCtD
Risperidone—Oedema—Betamethasone—psoriasis	5.48e-05	0.00014	CcSEcCtD
Risperidone—Anaphylactic shock—Betamethasone—psoriasis	5.48e-05	0.00014	CcSEcCtD
Risperidone—Insomnia—Triamcinolone—psoriasis	5.46e-05	0.000139	CcSEcCtD
Risperidone—Infection—Betamethasone—psoriasis	5.44e-05	0.000139	CcSEcCtD
Risperidone—Infection—Dexamethasone—psoriasis	5.44e-05	0.000139	CcSEcCtD
Risperidone—Ill-defined disorder—Prednisone—psoriasis	5.42e-05	0.000138	CcSEcCtD
Risperidone—Paraesthesia—Triamcinolone—psoriasis	5.42e-05	0.000138	CcSEcCtD
Risperidone—Feeling abnormal—Prednisolone—psoriasis	5.41e-05	0.000138	CcSEcCtD
Risperidone—Visual impairment—Methotrexate—psoriasis	5.41e-05	0.000138	CcSEcCtD
Risperidone—Anaemia—Prednisone—psoriasis	5.4e-05	0.000138	CcSEcCtD
Risperidone—Shock—Betamethasone—psoriasis	5.39e-05	0.000137	CcSEcCtD
Risperidone—Shock—Dexamethasone—psoriasis	5.39e-05	0.000137	CcSEcCtD
Risperidone—Dyspnoea—Triamcinolone—psoriasis	5.38e-05	0.000137	CcSEcCtD
Risperidone—Nervous system disorder—Dexamethasone—psoriasis	5.37e-05	0.000137	CcSEcCtD
Risperidone—Nervous system disorder—Betamethasone—psoriasis	5.37e-05	0.000137	CcSEcCtD
Risperidone—Agitation—Prednisone—psoriasis	5.37e-05	0.000137	CcSEcCtD
Risperidone—Thrombocytopenia—Dexamethasone—psoriasis	5.36e-05	0.000137	CcSEcCtD
Risperidone—Thrombocytopenia—Betamethasone—psoriasis	5.36e-05	0.000137	CcSEcCtD
Risperidone—Tachycardia—Dexamethasone—psoriasis	5.35e-05	0.000136	CcSEcCtD
Risperidone—Tachycardia—Betamethasone—psoriasis	5.35e-05	0.000136	CcSEcCtD
Risperidone—Angioedema—Prednisone—psoriasis	5.34e-05	0.000136	CcSEcCtD
Risperidone—Hypersensitivity—Cyclosporine—psoriasis	5.32e-05	0.000136	CcSEcCtD
Risperidone—Dyspepsia—Triamcinolone—psoriasis	5.31e-05	0.000136	CcSEcCtD
Risperidone—Erythema multiforme—Methotrexate—psoriasis	5.31e-05	0.000135	CcSEcCtD
Risperidone—Nausea—Mycophenolic acid—psoriasis	5.3e-05	0.000135	CcSEcCtD
Risperidone—Hyperhidrosis—Dexamethasone—psoriasis	5.3e-05	0.000135	CcSEcCtD
Risperidone—Hyperhidrosis—Betamethasone—psoriasis	5.3e-05	0.000135	CcSEcCtD
Risperidone—Feeling abnormal—Hydrocortisone—psoriasis	5.28e-05	0.000135	CcSEcCtD
Risperidone—Malaise—Prednisone—psoriasis	5.27e-05	0.000134	CcSEcCtD
Risperidone—Vertigo—Prednisone—psoriasis	5.25e-05	0.000134	CcSEcCtD
Risperidone—Eye disorder—Methotrexate—psoriasis	5.24e-05	0.000134	CcSEcCtD
Risperidone—Gastrointestinal pain—Hydrocortisone—psoriasis	5.24e-05	0.000134	CcSEcCtD
Risperidone—Syncope—Prednisone—psoriasis	5.24e-05	0.000134	CcSEcCtD
Risperidone—Tinnitus—Methotrexate—psoriasis	5.23e-05	0.000133	CcSEcCtD
Risperidone—Anorexia—Dexamethasone—psoriasis	5.22e-05	0.000133	CcSEcCtD
Risperidone—Anorexia—Betamethasone—psoriasis	5.22e-05	0.000133	CcSEcCtD
Risperidone—Urticaria—Prednisolone—psoriasis	5.22e-05	0.000133	CcSEcCtD
Risperidone—Cardiac disorder—Methotrexate—psoriasis	5.21e-05	0.000133	CcSEcCtD
Risperidone—Fatigue—Triamcinolone—psoriasis	5.21e-05	0.000133	CcSEcCtD
Risperidone—Hypersensitivity—Mycophenolate mofetil—psoriasis	5.19e-05	0.000132	CcSEcCtD
Risperidone—Asthenia—Cyclosporine—psoriasis	5.18e-05	0.000132	CcSEcCtD
Risperidone—Pain—Triamcinolone—psoriasis	5.16e-05	0.000132	CcSEcCtD
Risperidone—Loss of consciousness—Prednisone—psoriasis	5.14e-05	0.000131	CcSEcCtD
Risperidone—Hypotension—Betamethasone—psoriasis	5.12e-05	0.000131	CcSEcCtD
Risperidone—Hypotension—Dexamethasone—psoriasis	5.12e-05	0.000131	CcSEcCtD
Risperidone—Pruritus—Cyclosporine—psoriasis	5.1e-05	0.00013	CcSEcCtD
Risperidone—Urticaria—Hydrocortisone—psoriasis	5.09e-05	0.00013	CcSEcCtD
Risperidone—Angiopathy—Methotrexate—psoriasis	5.09e-05	0.00013	CcSEcCtD
Risperidone—Immune system disorder—Methotrexate—psoriasis	5.07e-05	0.000129	CcSEcCtD
Risperidone—Abdominal pain—Hydrocortisone—psoriasis	5.07e-05	0.000129	CcSEcCtD
Risperidone—Body temperature increased—Hydrocortisone—psoriasis	5.07e-05	0.000129	CcSEcCtD
Risperidone—Convulsion—Prednisone—psoriasis	5.07e-05	0.000129	CcSEcCtD
Risperidone—Mediastinal disorder—Methotrexate—psoriasis	5.06e-05	0.000129	CcSEcCtD
Risperidone—Asthenia—Mycophenolate mofetil—psoriasis	5.05e-05	0.000129	CcSEcCtD
Risperidone—Hypertension—Prednisone—psoriasis	5.05e-05	0.000129	CcSEcCtD
Risperidone—Chills—Methotrexate—psoriasis	5.04e-05	0.000128	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Dexamethasone—psoriasis	4.99e-05	0.000127	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Betamethasone—psoriasis	4.99e-05	0.000127	CcSEcCtD
Risperidone—Pruritus—Mycophenolate mofetil—psoriasis	4.98e-05	0.000127	CcSEcCtD
Risperidone—Arthralgia—Prednisone—psoriasis	4.98e-05	0.000127	CcSEcCtD
Risperidone—Myalgia—Prednisone—psoriasis	4.98e-05	0.000127	CcSEcCtD
Risperidone—Feeling abnormal—Triamcinolone—psoriasis	4.98e-05	0.000127	CcSEcCtD
Risperidone—Anxiety—Prednisone—psoriasis	4.96e-05	0.000126	CcSEcCtD
Risperidone—Alopecia—Methotrexate—psoriasis	4.96e-05	0.000126	CcSEcCtD
Risperidone—Insomnia—Dexamethasone—psoriasis	4.96e-05	0.000126	CcSEcCtD
Risperidone—Insomnia—Betamethasone—psoriasis	4.96e-05	0.000126	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	4.94e-05	0.000126	CcSEcCtD
Risperidone—Diarrhoea—Cyclosporine—psoriasis	4.94e-05	0.000126	CcSEcCtD
Risperidone—Paraesthesia—Betamethasone—psoriasis	4.92e-05	0.000125	CcSEcCtD
Risperidone—Paraesthesia—Dexamethasone—psoriasis	4.92e-05	0.000125	CcSEcCtD
Risperidone—Discomfort—Prednisone—psoriasis	4.92e-05	0.000125	CcSEcCtD
Risperidone—Mental disorder—Methotrexate—psoriasis	4.92e-05	0.000125	CcSEcCtD
Risperidone—Erythema—Methotrexate—psoriasis	4.89e-05	0.000125	CcSEcCtD
Risperidone—Malnutrition—Methotrexate—psoriasis	4.89e-05	0.000125	CcSEcCtD
Risperidone—Hypersensitivity—Prednisolone—psoriasis	4.84e-05	0.000123	CcSEcCtD
Risperidone—Dyspepsia—Dexamethasone—psoriasis	4.82e-05	0.000123	CcSEcCtD
Risperidone—Dyspepsia—Betamethasone—psoriasis	4.82e-05	0.000123	CcSEcCtD
Risperidone—Diarrhoea—Mycophenolate mofetil—psoriasis	4.82e-05	0.000123	CcSEcCtD
Risperidone—Urticaria—Triamcinolone—psoriasis	4.8e-05	0.000122	CcSEcCtD
Risperidone—Dysgeusia—Methotrexate—psoriasis	4.78e-05	0.000122	CcSEcCtD
Risperidone—Body temperature increased—Triamcinolone—psoriasis	4.77e-05	0.000122	CcSEcCtD
Risperidone—Dizziness—Cyclosporine—psoriasis	4.77e-05	0.000122	CcSEcCtD
Risperidone—Anaphylactic shock—Prednisone—psoriasis	4.77e-05	0.000122	CcSEcCtD
Risperidone—Oedema—Prednisone—psoriasis	4.77e-05	0.000122	CcSEcCtD
Risperidone—Decreased appetite—Dexamethasone—psoriasis	4.76e-05	0.000121	CcSEcCtD
Risperidone—Decreased appetite—Betamethasone—psoriasis	4.76e-05	0.000121	CcSEcCtD
Risperidone—Infection—Prednisone—psoriasis	4.74e-05	0.000121	CcSEcCtD
Risperidone—Gastrointestinal disorder—Dexamethasone—psoriasis	4.73e-05	0.000121	CcSEcCtD
Risperidone—Gastrointestinal disorder—Betamethasone—psoriasis	4.73e-05	0.000121	CcSEcCtD
Risperidone—Back pain—Methotrexate—psoriasis	4.73e-05	0.000121	CcSEcCtD
Risperidone—Hypersensitivity—Hydrocortisone—psoriasis	4.72e-05	0.00012	CcSEcCtD
Risperidone—Fatigue—Betamethasone—psoriasis	4.72e-05	0.00012	CcSEcCtD
Risperidone—Fatigue—Dexamethasone—psoriasis	4.72e-05	0.00012	CcSEcCtD
Risperidone—Shock—Prednisone—psoriasis	4.69e-05	0.00012	CcSEcCtD
Risperidone—Pain—Betamethasone—psoriasis	4.68e-05	0.000119	CcSEcCtD
Risperidone—Pain—Dexamethasone—psoriasis	4.68e-05	0.000119	CcSEcCtD
Risperidone—Nervous system disorder—Prednisone—psoriasis	4.68e-05	0.000119	CcSEcCtD
Risperidone—Tachycardia—Prednisone—psoriasis	4.66e-05	0.000119	CcSEcCtD
Risperidone—Dizziness—Mycophenolate mofetil—psoriasis	4.65e-05	0.000119	CcSEcCtD
Risperidone—Skin disorder—Prednisone—psoriasis	4.63e-05	0.000118	CcSEcCtD
Risperidone—Hyperhidrosis—Prednisone—psoriasis	4.61e-05	0.000118	CcSEcCtD
Risperidone—Vision blurred—Methotrexate—psoriasis	4.6e-05	0.000117	CcSEcCtD
Risperidone—Asthenia—Hydrocortisone—psoriasis	4.6e-05	0.000117	CcSEcCtD
Risperidone—Vomiting—Cyclosporine—psoriasis	4.59e-05	0.000117	CcSEcCtD
Risperidone—Rash—Cyclosporine—psoriasis	4.55e-05	0.000116	CcSEcCtD
Risperidone—Anorexia—Prednisone—psoriasis	4.55e-05	0.000116	CcSEcCtD
Risperidone—Dermatitis—Cyclosporine—psoriasis	4.55e-05	0.000116	CcSEcCtD
Risperidone—Pruritus—Hydrocortisone—psoriasis	4.54e-05	0.000116	CcSEcCtD
Risperidone—Ill-defined disorder—Methotrexate—psoriasis	4.53e-05	0.000116	CcSEcCtD
Risperidone—Headache—Cyclosporine—psoriasis	4.52e-05	0.000115	CcSEcCtD
Risperidone—Anaemia—Methotrexate—psoriasis	4.52e-05	0.000115	CcSEcCtD
Risperidone—Feeling abnormal—Betamethasone—psoriasis	4.51e-05	0.000115	CcSEcCtD
Risperidone—Feeling abnormal—Dexamethasone—psoriasis	4.51e-05	0.000115	CcSEcCtD
Risperidone—Gastrointestinal pain—Dexamethasone—psoriasis	4.48e-05	0.000114	CcSEcCtD
Risperidone—Gastrointestinal pain—Betamethasone—psoriasis	4.48e-05	0.000114	CcSEcCtD
Risperidone—Vomiting—Mycophenolate mofetil—psoriasis	4.48e-05	0.000114	CcSEcCtD
Risperidone—Hypersensitivity—Triamcinolone—psoriasis	4.45e-05	0.000113	CcSEcCtD
Risperidone—Rash—Mycophenolate mofetil—psoriasis	4.44e-05	0.000113	CcSEcCtD
Risperidone—Dermatitis—Mycophenolate mofetil—psoriasis	4.43e-05	0.000113	CcSEcCtD
Risperidone—Headache—Mycophenolate mofetil—psoriasis	4.41e-05	0.000112	CcSEcCtD
Risperidone—Malaise—Methotrexate—psoriasis	4.41e-05	0.000112	CcSEcCtD
Risperidone—Vertigo—Methotrexate—psoriasis	4.39e-05	0.000112	CcSEcCtD
Risperidone—Diarrhoea—Hydrocortisone—psoriasis	4.39e-05	0.000112	CcSEcCtD
Risperidone—Leukopenia—Methotrexate—psoriasis	4.37e-05	0.000112	CcSEcCtD
Risperidone—Urticaria—Dexamethasone—psoriasis	4.35e-05	0.000111	CcSEcCtD
Risperidone—Urticaria—Betamethasone—psoriasis	4.35e-05	0.000111	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Prednisone—psoriasis	4.35e-05	0.000111	CcSEcCtD
Risperidone—Dizziness—Prednisolone—psoriasis	4.34e-05	0.000111	CcSEcCtD
Risperidone—Asthenia—Triamcinolone—psoriasis	4.33e-05	0.00011	CcSEcCtD
Risperidone—Abdominal pain—Betamethasone—psoriasis	4.33e-05	0.00011	CcSEcCtD
Risperidone—Abdominal pain—Dexamethasone—psoriasis	4.33e-05	0.00011	CcSEcCtD
Risperidone—Body temperature increased—Betamethasone—psoriasis	4.33e-05	0.00011	CcSEcCtD
Risperidone—Body temperature increased—Dexamethasone—psoriasis	4.33e-05	0.00011	CcSEcCtD
Risperidone—Insomnia—Prednisone—psoriasis	4.32e-05	0.00011	CcSEcCtD
Risperidone—Nausea—Cyclosporine—psoriasis	4.29e-05	0.000109	CcSEcCtD
Risperidone—Paraesthesia—Prednisone—psoriasis	4.28e-05	0.000109	CcSEcCtD
Risperidone—Pruritus—Triamcinolone—psoriasis	4.27e-05	0.000109	CcSEcCtD
Risperidone—Cough—Methotrexate—psoriasis	4.26e-05	0.000109	CcSEcCtD
Risperidone—Dizziness—Hydrocortisone—psoriasis	4.24e-05	0.000108	CcSEcCtD
Risperidone—Convulsion—Methotrexate—psoriasis	4.23e-05	0.000108	CcSEcCtD
Risperidone—Dyspepsia—Prednisone—psoriasis	4.2e-05	0.000107	CcSEcCtD
Risperidone—Nausea—Mycophenolate mofetil—psoriasis	4.18e-05	0.000107	CcSEcCtD
Risperidone—Myalgia—Methotrexate—psoriasis	4.16e-05	0.000106	CcSEcCtD
Risperidone—Chest pain—Methotrexate—psoriasis	4.16e-05	0.000106	CcSEcCtD
Risperidone—Arthralgia—Methotrexate—psoriasis	4.16e-05	0.000106	CcSEcCtD
Risperidone—Decreased appetite—Prednisone—psoriasis	4.15e-05	0.000106	CcSEcCtD
Risperidone—Rash—Prednisolone—psoriasis	4.14e-05	0.000106	CcSEcCtD
Risperidone—Dermatitis—Prednisolone—psoriasis	4.14e-05	0.000105	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	4.13e-05	0.000105	CcSEcCtD
Risperidone—Fatigue—Prednisone—psoriasis	4.11e-05	0.000105	CcSEcCtD
Risperidone—Headache—Prednisolone—psoriasis	4.11e-05	0.000105	CcSEcCtD
Risperidone—Discomfort—Methotrexate—psoriasis	4.11e-05	0.000105	CcSEcCtD
Risperidone—Constipation—Prednisone—psoriasis	4.08e-05	0.000104	CcSEcCtD
Risperidone—Vomiting—Hydrocortisone—psoriasis	4.08e-05	0.000104	CcSEcCtD
Risperidone—Rash—Hydrocortisone—psoriasis	4.04e-05	0.000103	CcSEcCtD
Risperidone—Dermatitis—Hydrocortisone—psoriasis	4.04e-05	0.000103	CcSEcCtD
Risperidone—Confusional state—Methotrexate—psoriasis	4.02e-05	0.000103	CcSEcCtD
Risperidone—Headache—Hydrocortisone—psoriasis	4.02e-05	0.000102	CcSEcCtD
Risperidone—Dizziness—Triamcinolone—psoriasis	3.99e-05	0.000102	CcSEcCtD
Risperidone—Anaphylactic shock—Methotrexate—psoriasis	3.99e-05	0.000102	CcSEcCtD
Risperidone—Infection—Methotrexate—psoriasis	3.96e-05	0.000101	CcSEcCtD
Risperidone—Feeling abnormal—Prednisone—psoriasis	3.93e-05	0.0001	CcSEcCtD
Risperidone—Asthenia—Betamethasone—psoriasis	3.93e-05	0.0001	CcSEcCtD
Risperidone—Asthenia—Dexamethasone—psoriasis	3.93e-05	0.0001	CcSEcCtD
Risperidone—Nervous system disorder—Methotrexate—psoriasis	3.91e-05	9.97e-05	CcSEcCtD
Risperidone—Thrombocytopenia—Methotrexate—psoriasis	3.9e-05	9.95e-05	CcSEcCtD
Risperidone—Gastrointestinal pain—Prednisone—psoriasis	3.9e-05	9.95e-05	CcSEcCtD
Risperidone—Nausea—Prednisolone—psoriasis	3.9e-05	9.94e-05	CcSEcCtD
Risperidone—Pruritus—Dexamethasone—psoriasis	3.88e-05	9.88e-05	CcSEcCtD
Risperidone—Pruritus—Betamethasone—psoriasis	3.88e-05	9.88e-05	CcSEcCtD
Risperidone—Skin disorder—Methotrexate—psoriasis	3.87e-05	9.88e-05	CcSEcCtD
Risperidone—Hyperhidrosis—Methotrexate—psoriasis	3.85e-05	9.83e-05	CcSEcCtD
Risperidone—Vomiting—Triamcinolone—psoriasis	3.84e-05	9.79e-05	CcSEcCtD
Risperidone—Nausea—Hydrocortisone—psoriasis	3.81e-05	9.71e-05	CcSEcCtD
Risperidone—Rash—Triamcinolone—psoriasis	3.81e-05	9.71e-05	CcSEcCtD
Risperidone—Dermatitis—Triamcinolone—psoriasis	3.8e-05	9.7e-05	CcSEcCtD
Risperidone—Anorexia—Methotrexate—psoriasis	3.8e-05	9.69e-05	CcSEcCtD
Risperidone—Urticaria—Prednisone—psoriasis	3.79e-05	9.66e-05	CcSEcCtD
Risperidone—Headache—Triamcinolone—psoriasis	3.78e-05	9.65e-05	CcSEcCtD
Risperidone—Abdominal pain—Prednisone—psoriasis	3.77e-05	9.62e-05	CcSEcCtD
Risperidone—Body temperature increased—Prednisone—psoriasis	3.77e-05	9.62e-05	CcSEcCtD
Risperidone—Diarrhoea—Betamethasone—psoriasis	3.75e-05	9.56e-05	CcSEcCtD
Risperidone—Diarrhoea—Dexamethasone—psoriasis	3.75e-05	9.56e-05	CcSEcCtD
Risperidone—Hypotension—Methotrexate—psoriasis	3.73e-05	9.5e-05	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Methotrexate—psoriasis	3.63e-05	9.26e-05	CcSEcCtD
Risperidone—Dizziness—Dexamethasone—psoriasis	3.62e-05	9.24e-05	CcSEcCtD
Risperidone—Dizziness—Betamethasone—psoriasis	3.62e-05	9.24e-05	CcSEcCtD
Risperidone—Insomnia—Methotrexate—psoriasis	3.61e-05	9.2e-05	CcSEcCtD
Risperidone—Nausea—Triamcinolone—psoriasis	3.59e-05	9.15e-05	CcSEcCtD
Risperidone—Paraesthesia—Methotrexate—psoriasis	3.58e-05	9.13e-05	CcSEcCtD
Risperidone—Dyspnoea—Methotrexate—psoriasis	3.55e-05	9.06e-05	CcSEcCtD
Risperidone—Somnolence—Methotrexate—psoriasis	3.54e-05	9.04e-05	CcSEcCtD
Risperidone—Hypersensitivity—Prednisone—psoriasis	3.52e-05	8.96e-05	CcSEcCtD
Risperidone—Dyspepsia—Methotrexate—psoriasis	3.51e-05	8.95e-05	CcSEcCtD
Risperidone—Vomiting—Dexamethasone—psoriasis	3.48e-05	8.88e-05	CcSEcCtD
Risperidone—Vomiting—Betamethasone—psoriasis	3.48e-05	8.88e-05	CcSEcCtD
Risperidone—Decreased appetite—Methotrexate—psoriasis	3.47e-05	8.84e-05	CcSEcCtD
Risperidone—Rash—Betamethasone—psoriasis	3.45e-05	8.81e-05	CcSEcCtD
Risperidone—Rash—Dexamethasone—psoriasis	3.45e-05	8.81e-05	CcSEcCtD
Risperidone—Dermatitis—Betamethasone—psoriasis	3.45e-05	8.8e-05	CcSEcCtD
Risperidone—Dermatitis—Dexamethasone—psoriasis	3.45e-05	8.8e-05	CcSEcCtD
Risperidone—Gastrointestinal disorder—Methotrexate—psoriasis	3.44e-05	8.78e-05	CcSEcCtD
Risperidone—Fatigue—Methotrexate—psoriasis	3.44e-05	8.77e-05	CcSEcCtD
Risperidone—Headache—Betamethasone—psoriasis	3.43e-05	8.75e-05	CcSEcCtD
Risperidone—Headache—Dexamethasone—psoriasis	3.43e-05	8.75e-05	CcSEcCtD
Risperidone—Asthenia—Prednisone—psoriasis	3.42e-05	8.73e-05	CcSEcCtD
Risperidone—Pain—Methotrexate—psoriasis	3.41e-05	8.69e-05	CcSEcCtD
Risperidone—Pruritus—Prednisone—psoriasis	3.38e-05	8.61e-05	CcSEcCtD
Risperidone—Feeling abnormal—Methotrexate—psoriasis	3.29e-05	8.38e-05	CcSEcCtD
Risperidone—Diarrhoea—Prednisone—psoriasis	3.26e-05	8.32e-05	CcSEcCtD
Risperidone—Gastrointestinal pain—Methotrexate—psoriasis	3.26e-05	8.31e-05	CcSEcCtD
Risperidone—Nausea—Dexamethasone—psoriasis	3.25e-05	8.3e-05	CcSEcCtD
Risperidone—Nausea—Betamethasone—psoriasis	3.25e-05	8.3e-05	CcSEcCtD
Risperidone—Urticaria—Methotrexate—psoriasis	3.17e-05	8.08e-05	CcSEcCtD
Risperidone—Dizziness—Prednisone—psoriasis	3.16e-05	8.04e-05	CcSEcCtD
Risperidone—Abdominal pain—Methotrexate—psoriasis	3.15e-05	8.04e-05	CcSEcCtD
Risperidone—Body temperature increased—Methotrexate—psoriasis	3.15e-05	8.04e-05	CcSEcCtD
Risperidone—Vomiting—Prednisone—psoriasis	3.03e-05	7.74e-05	CcSEcCtD
Risperidone—Rash—Prednisone—psoriasis	3.01e-05	7.67e-05	CcSEcCtD
Risperidone—Dermatitis—Prednisone—psoriasis	3.01e-05	7.66e-05	CcSEcCtD
Risperidone—Headache—Prednisone—psoriasis	2.99e-05	7.62e-05	CcSEcCtD
Risperidone—Hypersensitivity—Methotrexate—psoriasis	2.94e-05	7.49e-05	CcSEcCtD
Risperidone—Asthenia—Methotrexate—psoriasis	2.86e-05	7.29e-05	CcSEcCtD
Risperidone—Nausea—Prednisone—psoriasis	2.83e-05	7.23e-05	CcSEcCtD
Risperidone—Pruritus—Methotrexate—psoriasis	2.82e-05	7.19e-05	CcSEcCtD
Risperidone—Diarrhoea—Methotrexate—psoriasis	2.73e-05	6.96e-05	CcSEcCtD
Risperidone—Dizziness—Methotrexate—psoriasis	2.64e-05	6.72e-05	CcSEcCtD
Risperidone—Vomiting—Methotrexate—psoriasis	2.54e-05	6.46e-05	CcSEcCtD
Risperidone—Rash—Methotrexate—psoriasis	2.51e-05	6.41e-05	CcSEcCtD
Risperidone—Dermatitis—Methotrexate—psoriasis	2.51e-05	6.4e-05	CcSEcCtD
Risperidone—Headache—Methotrexate—psoriasis	2.5e-05	6.37e-05	CcSEcCtD
Risperidone—Nausea—Methotrexate—psoriasis	2.37e-05	6.04e-05	CcSEcCtD
Risperidone—ADRA2A—Hemostasis—VEGFA—psoriasis	1.04e-05	0.000237	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—TYK2—psoriasis	1.04e-05	0.000237	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—NFKBIA—psoriasis	1.04e-05	0.000237	CbGpPWpGaD
Risperidone—ADRA2B—Hemostasis—TP53—psoriasis	1.03e-05	0.000236	CbGpPWpGaD
Risperidone—HTR1A—GPCR downstream signaling—CXCL8—psoriasis	1.03e-05	0.000235	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—LEP—psoriasis	1.02e-05	0.000234	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—APOE—psoriasis	1.02e-05	0.000234	CbGpPWpGaD
Risperidone—HTR2C—GPCR downstream signaling—CXCL8—psoriasis	1.02e-05	0.000233	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—TYK2—psoriasis	1.02e-05	0.000233	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—NFKBIA—psoriasis	1.01e-05	0.000232	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—CAT—psoriasis	1e-05	0.000229	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—NFKBIA—psoriasis	9.97e-06	0.000228	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—CXCL8—psoriasis	9.93e-06	0.000227	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—APOE—psoriasis	9.87e-06	0.000226	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—SOCS1—psoriasis	9.86e-06	0.000225	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—CXCL8—psoriasis	9.78e-06	0.000223	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—SOCS1—psoriasis	9.7e-06	0.000222	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—SOCS1—psoriasis	9.68e-06	0.000221	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—CXCL8—psoriasis	9.66e-06	0.000221	CbGpPWpGaD
Risperidone—ADRA2C—Hemostasis—TP53—psoriasis	9.64e-06	0.00022	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—LEP—psoriasis	9.64e-06	0.00022	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—APOE—psoriasis	9.64e-06	0.00022	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—APOE—psoriasis	9.59e-06	0.000219	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—NFKBIA—psoriasis	9.52e-06	0.000218	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—LEP—psoriasis	9.51e-06	0.000217	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—APOE—psoriasis	9.51e-06	0.000217	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—SOCS1—psoriasis	9.5e-06	0.000217	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—TYK2—psoriasis	9.4e-06	0.000215	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—CXCL8—psoriasis	9.32e-06	0.000213	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—CXCL8—psoriasis	9.27e-06	0.000212	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—TYK2—psoriasis	9.25e-06	0.000211	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—TYK2—psoriasis	9.23e-06	0.000211	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—CAT—psoriasis	9.19e-06	0.00021	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—TYK2—psoriasis	9.06e-06	0.000207	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—CXCL8—psoriasis	9.02e-06	0.000206	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—CXCL8—psoriasis	9.01e-06	0.000206	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—NFKBIA—psoriasis	8.98e-06	0.000205	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—CXCL8—psoriasis	8.88e-06	0.000203	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—CXCL8—psoriasis	8.87e-06	0.000203	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—NFKBIA—psoriasis	8.86e-06	0.000202	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—CXCL8—psoriasis	8.85e-06	0.000202	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—SOCS1—psoriasis	8.82e-06	0.000202	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—CXCL8—psoriasis	8.68e-06	0.000198	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—PPARG—psoriasis	8.6e-06	0.000197	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—LEP—psoriasis	8.58e-06	0.000196	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—APOE—psoriasis	8.58e-06	0.000196	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—TYK2—psoriasis	8.53e-06	0.000195	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—TYK2—psoriasis	8.48e-06	0.000194	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—TYK2—psoriasis	8.41e-06	0.000192	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—PPARG—psoriasis	8.35e-06	0.000191	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TYK2—psoriasis	8.3e-06	0.00019	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—LEP—psoriasis	8.29e-06	0.000189	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—APOE—psoriasis	8.29e-06	0.000189	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—APOE—psoriasis	8.24e-06	0.000188	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—LEP—psoriasis	8.24e-06	0.000188	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—CXCL8—psoriasis	8.18e-06	0.000187	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TYK2—psoriasis	8.17e-06	0.000187	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—CXCL8—psoriasis	8.07e-06	0.000184	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—CXCL8—psoriasis	8.05e-06	0.000184	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—CXCL8—psoriasis	8.04e-06	0.000184	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—LEP—psoriasis	8.02e-06	0.000183	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—APOE—psoriasis	8.02e-06	0.000183	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—NFKBIA—psoriasis	8e-06	0.000183	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—APOE—psoriasis	7.89e-06	0.00018	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—LEP—psoriasis	7.89e-06	0.00018	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—CXCL8—psoriasis	7.88e-06	0.00018	CbGpPWpGaD
Risperidone—ADRA2A—Hemostasis—TP53—psoriasis	7.83e-06	0.000179	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TYK2—psoriasis	7.8e-06	0.000178	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—APOE—psoriasis	7.79e-06	0.000178	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—NFKBIA—psoriasis	7.72e-06	0.000176	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—NFKBIA—psoriasis	7.68e-06	0.000176	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—NFKBIA—psoriasis	7.47e-06	0.000171	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—CXCL8—psoriasis	7.43e-06	0.00017	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—CXCL8—psoriasis	7.38e-06	0.000169	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TYK2—psoriasis	7.35e-06	0.000168	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—NFKBIA—psoriasis	7.35e-06	0.000168	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—CXCL8—psoriasis	7.33e-06	0.000167	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—LEP—psoriasis	7.28e-06	0.000166	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—APOE—psoriasis	7.28e-06	0.000166	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TYK2—psoriasis	7.26e-06	0.000166	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—CXCL8—psoriasis	7.23e-06	0.000165	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—LEP—psoriasis	7.16e-06	0.000164	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—APOE—psoriasis	7.16e-06	0.000164	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—LEP—psoriasis	7.14e-06	0.000163	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—APOE—psoriasis	7.14e-06	0.000163	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—APOE—psoriasis	7.14e-06	0.000163	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—CXCL8—psoriasis	7.11e-06	0.000163	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—IL6—psoriasis	7.07e-06	0.000161	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—IL6—psoriasis	7.02e-06	0.00016	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—LEP—psoriasis	7.01e-06	0.00016	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—APOE—psoriasis	7.01e-06	0.00016	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CARM1—psoriasis	6.94e-06	0.000159	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—CAT—psoriasis	6.93e-06	0.000158	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—JUN—psoriasis	6.91e-06	0.000158	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—IL6—psoriasis	6.87e-06	0.000157	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—JUN—psoriasis	6.86e-06	0.000157	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—CXCL8—psoriasis	6.79e-06	0.000155	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—PPARG—psoriasis	6.78e-06	0.000155	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—NFKBIA—psoriasis	6.78e-06	0.000155	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—IL6—psoriasis	6.76e-06	0.000155	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—JUN—psoriasis	6.72e-06	0.000154	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—NFKBIA—psoriasis	6.67e-06	0.000152	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—NFKBIA—psoriasis	6.66e-06	0.000152	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—NFKB1—psoriasis	6.65e-06	0.000152	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—JUN—psoriasis	6.61e-06	0.000151	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—NFKB1—psoriasis	6.61e-06	0.000151	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TYK2—psoriasis	6.55e-06	0.00015	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—CAT—psoriasis	6.53e-06	0.000149	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—NFKBIA—psoriasis	6.53e-06	0.000149	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—APOE—psoriasis	6.51e-06	0.000149	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—LEP—psoriasis	6.51e-06	0.000149	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—NFKB1—psoriasis	6.47e-06	0.000148	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—IL6—psoriasis	6.46e-06	0.000148	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—CXCL8—psoriasis	6.4e-06	0.000146	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—NFKB1—psoriasis	6.37e-06	0.000145	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TYK2—psoriasis	6.32e-06	0.000145	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—CXCL8—psoriasis	6.32e-06	0.000144	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—JUN—psoriasis	6.31e-06	0.000144	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TYK2—psoriasis	6.29e-06	0.000144	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PPARG—psoriasis	6.22e-06	0.000142	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TYK2—psoriasis	6.12e-06	0.00014	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—IL6—psoriasis	6.09e-06	0.000139	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—NFKB1—psoriasis	6.08e-06	0.000139	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—NFKBIA—psoriasis	6.07e-06	0.000139	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—VEGFA—psoriasis	6.03e-06	0.000138	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TYK2—psoriasis	6.02e-06	0.000138	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—IL6—psoriasis	6.01e-06	0.000137	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—VEGFA—psoriasis	6e-06	0.000137	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—STAT3—psoriasis	5.98e-06	0.000137	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—JUN—psoriasis	5.95e-06	0.000136	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—STAT3—psoriasis	5.94e-06	0.000136	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—JUN—psoriasis	5.87e-06	0.000134	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—VEGFA—psoriasis	5.87e-06	0.000134	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—STAT3—psoriasis	5.81e-06	0.000133	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—VEGFA—psoriasis	5.78e-06	0.000132	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—NFKB1—psoriasis	5.73e-06	0.000131	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—STAT3—psoriasis	5.72e-06	0.000131	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CXCL8—psoriasis	5.7e-06	0.00013	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—NFKB1—psoriasis	5.65e-06	0.000129	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TYK2—psoriasis	5.55e-06	0.000127	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—VEGFA—psoriasis	5.51e-06	0.000126	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CXCL8—psoriasis	5.51e-06	0.000126	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CXCL8—psoriasis	5.48e-06	0.000125	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TYK2—psoriasis	5.46e-06	0.000125	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—STAT3—psoriasis	5.46e-06	0.000125	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TYK2—psoriasis	5.45e-06	0.000125	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—IL6—psoriasis	5.42e-06	0.000124	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—APOE—psoriasis	5.39e-06	0.000123	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TYK2—psoriasis	5.35e-06	0.000122	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CXCL8—psoriasis	5.33e-06	0.000122	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—JUN—psoriasis	5.3e-06	0.000121	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CXCL8—psoriasis	5.24e-06	0.00012	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—IL6—psoriasis	5.24e-06	0.00012	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—IL6—psoriasis	5.21e-06	0.000119	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—VEGFA—psoriasis	5.2e-06	0.000119	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—STAT3—psoriasis	5.15e-06	0.000118	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—VEGFA—psoriasis	5.13e-06	0.000117	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—JUN—psoriasis	5.12e-06	0.000117	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—NFKB1—psoriasis	5.1e-06	0.000117	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—JUN—psoriasis	5.09e-06	0.000116	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—STAT3—psoriasis	5.08e-06	0.000116	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—APOE—psoriasis	5.08e-06	0.000116	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—IL6—psoriasis	5.07e-06	0.000116	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—IL6—psoriasis	4.99e-06	0.000114	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TYK2—psoriasis	4.97e-06	0.000114	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—JUN—psoriasis	4.95e-06	0.000113	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—NFKB1—psoriasis	4.93e-06	0.000113	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—NFKB1—psoriasis	4.9e-06	0.000112	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—JUN—psoriasis	4.88e-06	0.000111	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CXCL8—psoriasis	4.83e-06	0.00011	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—NFKB1—psoriasis	4.77e-06	0.000109	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CXCL8—psoriasis	4.76e-06	0.000109	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CXCL8—psoriasis	4.75e-06	0.000108	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—NFKB1—psoriasis	4.69e-06	0.000107	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PPARG—psoriasis	4.69e-06	0.000107	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CXCL8—psoriasis	4.66e-06	0.000106	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—VEGFA—psoriasis	4.63e-06	0.000106	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—IL6—psoriasis	4.6e-06	0.000105	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—STAT3—psoriasis	4.59e-06	0.000105	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—TP53—psoriasis	4.56e-06	0.000104	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—TP53—psoriasis	4.53e-06	0.000104	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—IL6—psoriasis	4.52e-06	0.000103	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—IL6—psoriasis	4.51e-06	0.000103	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—JUN—psoriasis	4.49e-06	0.000103	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—VEGFA—psoriasis	4.47e-06	0.000102	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—VEGFA—psoriasis	4.45e-06	0.000102	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TP53—psoriasis	4.44e-06	0.000101	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—IL6—psoriasis	4.43e-06	0.000101	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—STAT3—psoriasis	4.43e-06	0.000101	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—JUN—psoriasis	4.42e-06	0.000101	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PPARG—psoriasis	4.42e-06	0.000101	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—JUN—psoriasis	4.41e-06	0.000101	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—STAT3—psoriasis	4.41e-06	0.000101	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TP53—psoriasis	4.37e-06	9.98e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—JUN—psoriasis	4.33e-06	9.9e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CXCL8—psoriasis	4.33e-06	9.89e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—VEGFA—psoriasis	4.33e-06	9.89e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—NFKB1—psoriasis	4.33e-06	9.89e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—STAT3—psoriasis	4.28e-06	9.79e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CAT—psoriasis	4.27e-06	9.76e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—VEGFA—psoriasis	4.26e-06	9.73e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—NFKB1—psoriasis	4.26e-06	9.73e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—NFKB1—psoriasis	4.25e-06	9.71e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—STAT3—psoriasis	4.22e-06	9.64e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—IL6—psoriasis	4.17e-06	9.54e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—NFKB1—psoriasis	4.17e-06	9.53e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TP53—psoriasis	4.17e-06	9.52e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—IL6—psoriasis	4.15e-06	9.48e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—IL6—psoriasis	4.12e-06	9.41e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—IL6—psoriasis	4.06e-06	9.28e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—JUN—psoriasis	4.02e-06	9.2e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—IL6—psoriasis	4e-06	9.13e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TP53—psoriasis	3.93e-06	8.98e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—VEGFA—psoriasis	3.93e-06	8.97e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—STAT3—psoriasis	3.89e-06	8.89e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TP53—psoriasis	3.88e-06	8.86e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—NFKB1—psoriasis	3.87e-06	8.85e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—VEGFA—psoriasis	3.86e-06	8.83e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—VEGFA—psoriasis	3.86e-06	8.81e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—STAT3—psoriasis	3.83e-06	8.74e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—STAT3—psoriasis	3.82e-06	8.72e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—IL6—psoriasis	3.81e-06	8.72e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—VEGFA—psoriasis	3.78e-06	8.65e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—STAT3—psoriasis	3.75e-06	8.56e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—IL6—psoriasis	3.6e-06	8.22e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—IL6—psoriasis	3.55e-06	8.11e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—VEGFA—psoriasis	3.51e-06	8.03e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TP53—psoriasis	3.5e-06	8e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—STAT3—psoriasis	3.48e-06	7.95e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TP53—psoriasis	3.38e-06	7.72e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TP53—psoriasis	3.36e-06	7.68e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—APOE—psoriasis	3.32e-06	7.58e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TP53—psoriasis	3.27e-06	7.47e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TP53—psoriasis	3.22e-06	7.35e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—IL6—psoriasis	3.2e-06	7.32e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—IL6—psoriasis	3.09e-06	7.07e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—IL6—psoriasis	3.08e-06	7.03e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—IL6—psoriasis	2.99e-06	6.84e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TP53—psoriasis	2.97e-06	6.78e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IL6—psoriasis	2.95e-06	6.73e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TP53—psoriasis	2.92e-06	6.67e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TP53—psoriasis	2.91e-06	6.66e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PPARG—psoriasis	2.89e-06	6.61e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TP53—psoriasis	2.86e-06	6.53e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IL6—psoriasis	2.72e-06	6.21e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IL6—psoriasis	2.67e-06	6.11e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IL6—psoriasis	2.67e-06	6.09e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TP53—psoriasis	2.66e-06	6.07e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IL6—psoriasis	2.62e-06	5.98e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IL6—psoriasis	2.43e-06	5.56e-05	CbGpPWpGaD
